TCIM
AMRX icon

TIAA CREF Investment Management’s Amneal Pharmaceuticals AMRX Stock Holding History

TIAA CREF Investment Management’s Portfolio AMRX Stock Details AMRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		$2.31M Sell
163,245
-1,047
-0.6% -$13.8K ﹤0.01% 1923
2018
Q4 		$2.22M Sell
164,292
-185,633
-53% -$3.35M ﹤0.01% 1897
2018
Q3 		$7.76M Buy
349,925
+96,813
+38% +$2.04M 0.01% 1265
2018
Q2 		$4.15M Buy
+253,112
New +$4.44M ﹤0.01% 1735

Other funds holding AMRX

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
FI
Fosun International Hong Kong, China $446M AUM 13.33% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
TGHSA
TPG Group Holdings (SBS) Advisors Fort Worth, Texas $10.1B AUM 22.58% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
TG
TCW Group Los Angeles, California $14.9B AUM 46.29% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

TIAA CREF Investment Management's AMRX Position: Q1 2019 in Review

TIAA CREF Investment Management reduced its Amneal Pharmaceuticals (AMRX) stake by 0.64% in Q1 2019, selling an estimated $13.8K and leaving 163,245 shares worth $2.31M. The position accounts for ﹤0.01% of the portfolio, ranked #1923.

TIAA CREF Investment Management first reported a position in AMRX in Q2 2018 and has held it in 4 quarters since. The position peaked at $7.76M in Q3 2018. 164 funds tracked by Wall St. Rank hold AMRX as of Q1 2019.

  • TIAA CREF Investment Management held 163,245 shares of Amneal Pharmaceuticals worth $2.31M as of Q1 2019.
  • TIAA CREF Investment Management sold 1,047 Amneal Pharmaceuticals shares in Q1 2019, an estimated $13.8K.
  • Amneal Pharmaceuticals made up ﹤0.01% of TIAA CREF Investment Management's portfolio in Q1 2019, its #1923 holding.
  • TIAA CREF Investment Management first reported a position in Amneal Pharmaceuticals in Q2 2018 and has held it in 4 quarters since.
  • TIAA CREF Investment Management's Amneal Pharmaceuticals position peaked at $7.76M in Q3 2018.
  • 164 funds tracked by Wall St. Rank held Amneal Pharmaceuticals as of Q1 2019.

Based on TIAA CREF Investment Management's 13F filing for Q1 2019, filed 14 May 2019.